You are reading the press release re: the May 15th DHC Proposed Draft Guidance for FDA Consideration. If you’re looking for the document itself, please click here.
[ed note, 5/17/2022: The opportunity to offer proposed draft guidance is open …
Walnut Creek, CA—Dark Horse Consulting (DHC) today announces the make-up of its Board of Directors.
Dark Horse Consulting, the rapidly growing global consulting practice specializing exclusively in cell and gene therapies, understands the challenges specific to C> sponsors, tool providers, …
Walnut Creek, CA—Dark Horse Consulting Group (DHC), the only global consulting practice specializing exclusively in cell and gene therapies, announces renowned FDA expert Donald Fink, Ph.D. as their latest hire.
After 27 years spent at the United States Food and …
SAN FRANCISCO /PRNewswire/ — Arcline Investment Management (“Arcline”), a growth oriented private equity firm with $1.5 billion of capital under management, today announced the formation of a strategic relationship with Dark Horse Consulting Group (“Dark Horse” or “the Company”). Taking …
Campbell, CA, January 21st, 2019 – Dark Horse Consulting, the leading consultancy specializing in cell and gene therapy product development, today announced its planned attendance and sponsorship of the 2019 Phacilitate Leaders World meeting, scheduled for January 22-25 in Miami, …
Campbell, CA, January 22, 2018 — Dark Horse Consulting, a leading provider of consulting services for the cell and gene therapy industry, today announced the appointment of Katy Spink, Ph.D. as a Managing Partner of the firm. Dr. Spink will …
Photo credit Anita Barcsa Photography
©2020 Dark Horse Consulting Group, Inc.
